CA
MXCT icon

Cliff Asness’s MaxCyte MXCT Stock Holding History

Cliff Asness’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.32M Buy
1,882,776
+661,594
+54% +$659K ﹤0.01% 2534
2026
Q1 		$858K Buy
1,221,182
+1,127,208
+1,199% +$1.05M ﹤0.01% 2860
2025
Q4 		$146K Sell
93,974
-297,019
-76% -$474K ﹤0.01% 3422
2025
Q3 		$618K Buy
390,993
+143,300
+58% +$249K ﹤0.01% 2703
2025
Q2 		$540K Buy
247,693
+152,192
+159% +$369K ﹤0.01% 2581
2025
Q1 		$261K Buy
95,501
+66,323
+227% +$261K ﹤0.01% 2751
2024
Q4 		$121K Buy
29,178
+16,613
+132% +$62.8K ﹤0.01% 2744
2024
Q3 		$48.9K Sell
12,565
-924
-7% -$3.89K ﹤0.01% 2706
2024
Q2 		$52.9K Sell
13,489
-1,906
-12% -$8.2K ﹤0.01% 2537
2024
Q1 		$64.5K Sell
15,395
-13,919
-47% -$65.3K ﹤0.01% 2367
2023
Q4 		$138K Buy
29,314
+13,450
+85% +$52.4K ﹤0.01% 2257
2023
Q3 		$49.5K Buy
+15,864
New +$63.8K ﹤0.01% 2285

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Cliff Asness's MXCT Position: Q2 2026 in Review

Cliff Asness increased its MaxCyte (MXCT) stake by 54% in Q2 2026, buying an estimated $659K and bringing the position to 1,882,776 shares worth $2.32M. The position accounts for ﹤0.01% of the portfolio, ranked #2534.

Cliff Asness first reported a position in MXCT in Q3 2023 and has held it in 12 quarters since. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Cliff Asness held 1,882,776 shares of MaxCyte worth $2.32M as of Q2 2026.
  • Cliff Asness bought 661,594 MaxCyte shares in Q2 2026, an estimated $659K.
  • MaxCyte made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #2534 holding.
  • Cliff Asness first reported a position in MaxCyte in Q3 2023 and has held it in 12 quarters since.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.